Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma

Part of paid clinical trials in Stanford, California.

Sponsor
Stanford University
Study ID
NCT01048281
Status
Recruiting
Apply to this trial

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Blood draw — PROCEDURE
  • Tissue tumor biopsy — PROCEDURE

Study Details

Our research of the biology of upper gastrointestinal cancers involves the study of tissue samples and cells from biopsies of persons with gastric or esophageal cancer or blood samples from upper gastrointestinal cancer patients and persons at high inherited risk for these cancers. We hope to learn the role genes and proteins play in the development of gastric and esophageal cancer.

Key Dates

Start date
Aug 31, 2002
Status verified
Dec 2025
Primary completion
Jan 31, 2099
Completion
Jan 31, 2099

Study Design

Enrollment
100 participants (estimated)

Primary Outcome Measure

p53 activity by routine pathologic analysis [ Time Frame: time of collection ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Stanford University School of MedicineStanfordCalifornia94305
Meredith Mills
[email protected]
650-724-5223
James M Ford (PRINCIPAL_INVESTIGATOR)
Hanlee P. Ji (SUB_INVESTIGATOR)
Vandana Bhardwaj Sharma (SUB_INVESTIGATOR)

Find similar trials in Stanford, CA

By condition
Esophageal cancerGastric cancer
By specialty
OncologyGI oncology
By research site
Stanford University School of Medicine· Stanford, CA

Related Studies